SYNLAB Emerging Markets and SYNLAB Group have announced the appointment of Patrick Asiamah as its new Chief Executive Officer effective March 1, 2022.
Prior to the appointment, Mr. Asiamah worked as Global Head of Portfolio & Product Marketing at mPharma, here in Ghana and abroad (Nigeria, Zambia and Kenya). He has worked in other multinational organizations such as Sandoz, Ernest Chemist (Johnson & Johnson) and Shalina Healthcare.
Patrick holds an Executive MBA in Marketing Strategy and a Degree in Biochemistry. He has 15 years of expertise in Sales and Marketing, including Business Development, Sustaining Market Share Gains, Wrestling Market Leadership, and Business Operation Strategies.
CEO of SYNLAB Emerging Market, Thomas Degott said “SYNLAB Ghana is positioned for significant growth, and we are thrilled Patrick has accepted this position, as it will allow him to bring the firm the tremendous opportunity that lies ahead for SYNLAB Ghana. We couldn’t be happier to have Patrick join our family and assist us and our clients achieve ongoing success”.
Patrick is eager to take a customer-focused healthcare organization like SYNLAB Ghana to the next level, with his many years of relevant experience.
“I am excited to be part of this team to deliver quality laboratory and radiology services to patients, doctors, and clients in Ghana. I believe, together, we can rewrite the narrative of SYNLAB Ghana and make an impact in the medical diagnostics space,” Mr Asiamah said.
SYNLAB is Europe’s number one Medical Diagnostics Provider offering quality diagnostics care to families and supporting medical professionals with specialized expertise.
SYNLAB leads the market in the accuracy, precision and reliability of its diagnostic results. It achieved ISO 15189 accreditation in 2008, as we set the pace for excellence in medical diagnostics in Ghana.
SYNLAB Ghana has offices in Accra, Tema, Kumasi, Takoradi, Koforidua and Sunyani.